Alto Neuroscience Appoints Biotech Industry Veteran, Raymond Sanchez
August 13, 2025
Alto Neuroscience, Inc., a clinical-stage biopharmaceutical company focused on developing precision medicines for neuropsychiatric disorders, has appointed Dr. Raymond Sanchez to its Board of Directors,